Chemomab Therapeutics Ltd. — Director's Dealing 2021

Apr 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-04-19

Reporting Person: Nicaise Claude (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-19	Option to Purchase American Depositary Shares	$27.26	A	11884	Acquired	2031-04-19	American Depositary Shares (11884)	Direct

Footnotes

F1: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.

F2: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.